Modern technologies in ophtalmology最新文献

A clinical case of intravitreal implant dexamethasone (Ozurdex) using in treatment of macular edema associated with non-infectious uveitis 玻璃体内植入地塞米松（Ozurdex）治疗非感染性葡萄膜炎相关黄斑水肿的临床病例

Modern technologies in ophtalmology Pub Date : 2023-10-29 DOI: 10.25276/2312-4911-2022-6-60-66

L. Danilova, O. V. Kolenko, D. Storozhilova, A.E. Shulga, L. P. Emanova

{"title":"A clinical case of intravitreal implant dexamethasone (Ozurdex) using in treatment of macular edema associated with non-infectious uveitis","authors":"L. Danilova, O. V. Kolenko, D. Storozhilova, A.E. Shulga, L. P. Emanova","doi":"10.25276/2312-4911-2022-6-60-66","DOIUrl":"https://doi.org/10.25276/2312-4911-2022-6-60-66","url":null,"abstract":"Purpose. Demonstration of a clinical case of macular edema treatment associated with non-infectious uveitis by intravitreal injection of a dexamethasone implant (Ozurdex). Material and methods. A clinical case of uveitis associated with rheumatoid arthritis in a 34-year-old female patient is presented. She underwent sequential two intravitreal injections (IVI) of long-acting dexamethasone (Ozurdex implants), with an interval of 3 months. Results. 3 days after Ozurdex IVI Vis OD = 1.0, Vis OS = 0.8 (initially 0.2), intraocular pressure (IOP) OD = 18 mmHg, IOP OS = 19 mmHg. A single cell suspension remained in the vitreous body. The retinal thickness in the macula decreased to 314.5 µm (initial 725.2 µm), and macula volume decreased to 14.1 mm³(initially 18.5 mm³ ). 3 months after IVI of Ozurdex in the vitreous: opacification +2 points, the implant was not detected due to its rapid biodegradation. OCT of the macular area again revealed edema with cystic cavities. Ozurdex was reinjected intravitreally. 3 days after the operation, all signs of the inflammatory process were stopped, Vis OD = 1.0, Vis OS = 1.0, IOP OD = 18 mmHg, IOP OS = 18 mmHg. Conclusion. The Ozurdex implant made it possible to achieve complete regression of macular edema and resorption of cell suspension in the vitreous body. The best-corrected visual acuity (BCVA) indicators increased significantly – from 0.4 to 1.0. Keywords: non-infectious uveitis, macular edema, Ozurdex implant, retinal thickness, macular volume.","PeriodicalId":18609,"journal":{"name":"Modern technologies in ophtalmology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139311762","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Diagnostic errors in penetrating wounds of the orbit in children 儿童眼眶穿透伤的诊断错误

Modern technologies in ophtalmology Pub Date : 2023-10-29 DOI: 10.25276/2312-4911-2022-6-107-112

A. M. Revta, A. M. Bezhanidze, A.V. Nikishenkova, T.A. Ryazantseva

引用次数: 0

Efficacy of physical therapies for recurrent corneal erosion of herpetic etiology 物理疗法对疱疹性复发性角膜糜烂的疗效

Modern technologies in ophtalmology Pub Date : 2023-10-29 DOI: 10.25276/2312-4911-2022-6-117-120

A.F. Smirnova, G. V. Kotlubey, V.S. Shevchenko, S.V. Chubar, K. Golubov

引用次数: 0

A clinical case of combination of acute attack of angle-closure glaucoma and acute anterior uveitis: competition or synergism 闭角型青光眼急性发作与急性前葡萄膜炎并发的临床病例：竞争还是协同作用

Modern technologies in ophtalmology Pub Date : 2023-10-29 DOI: 10.25276/2312-4911-2022-6-46-51

I. Gndoyan, K. S. Trishkin, K.A. Akhmedov

引用次数: 0

Clinical course and treatment of chronic conjunctivitis in the Southern Aral Sea region 咸海南部地区慢性结膜炎的临床过程和治疗方法

Modern technologies in ophtalmology Pub Date : 2023-10-29 DOI: 10.25276/2312-4911-2022-6-26-32

F. Bakhritdinova, A. K. Matkarimov, Z. R. Maksudova

{"title":"Clinical course and treatment of chronic conjunctivitis in the Southern Aral Sea region","authors":"F. Bakhritdinova, A. K. Matkarimov, Z. R. Maksudova","doi":"10.25276/2312-4911-2022-6-26-32","DOIUrl":"https://doi.org/10.25276/2312-4911-2022-6-26-32","url":null,"abstract":"Purpose. Optimization of treatment of chronic conjunctivitis in the Southern Aral Sea region. Material and Methods. The research included 62 patients (120 eyes) with chronic conjunctivitis, aged 35–62 years, who had been observed in a polyclinic for the last 3 years, with signs of DES. All studied patients were divided into 2 groups by random sampling after preliminary adequate antibacterial and anti-inflammatory therapy; The control group (20 patients, 40 eyes) was instilled with an antiseptic - Tsinosol (composition: zinc sulphate, boric acid, Aseptic), 2 drops 3 times a day, for 30 days. In the main group (40 patients, 80 eyes), patients were instilled with an antiseptic - Tsinosol (2 drops 3 times a day) and an artificial tear (AT) medicine - Keratrop (composition: sodium carmellose, glycerin, levocarnitine, erythrolfirma Aseptica), 2 drops 3 times a day for a month. All patients underwent standard ophthalmological tests, and special studies were carried out to verify DES, including tests by Schirmer, Norn, Jones, the height of the lower lacrimal meniscus and the severity of the conjunctival fold were determined. Results. Studies have shown that in the main group, both subjective and objective signs of the disease significantly decreased compared with the baseline and with the data of the control group, and a significant improvement in the stability of the tear film was noted. Conclusion. To optimize the therapy of secondary DES, it is necessary to include in the treatment regimen AT medicines in general and the domestic medicine Keratrop in particular, as the medicine of choice in this region. Keywords: Southern Aral Sea region, environment, chronic conjunctivitis, dry eye syndrome (DES), DES treatment, tear substitutes","PeriodicalId":18609,"journal":{"name":"Modern technologies in ophtalmology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139311756","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Clinical case of scleromalacia in a patient with rheumatoid arthritis after intravitreal interventions 一名类风湿性关节炎患者在接受玻璃体内介入治疗后出现硬膜囊肿的临床病例

Modern technologies in ophtalmology Pub Date : 2023-10-29 DOI: 10.25276/2312-4911-2022-6-91-97

M.G. Kataev, I.Y. Trofimova, O.A. Gorbacheva, A.A. Zasypkina

{"title":"Clinical case of scleromalacia in a patient with rheumatoid arthritis after intravitreal interventions","authors":"M.G. Kataev, I.Y. Trofimova, O.A. Gorbacheva, A.A. Zasypkina","doi":"10.25276/2312-4911-2022-6-91-97","DOIUrl":"https://doi.org/10.25276/2312-4911-2022-6-91-97","url":null,"abstract":"One of the manifestations of scleritis is perforating scleromalacia (necrotizing anterior scleritis without inflammation), characterized by an almost complete absence of clinical manifestations and usually associated with systemic diseases or postoperative complications. Scleromalacia is a serious, progressive disease that is difficult to treat and can lead to vision loss, perforation and loss of the eye as an organ. Treatment of such patients requires an integrated approach together with rheumatologists and is difficult, despite the many already proposed methods of surgical treatment using various grafts and implants. The purpose of the presented clinical case is to increase the effectiveness of surgical treatment of scleromalacia by using a method of scleroplasty using an autograft of the temporal fascia using the example of patient K. with rheumatoid arthritis and a history of repeated to contents к содержанию microinvasive vitrectomy. Objective data of preoperative and postoperative diagnostics in the early and late postoperative periods are presented. The obtained result of the presented surgical treatment can be recommended as a method of treating scleromalacia in clinical practice. as well as postoperative diagnostics in the early and late postoperative periods. The obtained result of the presented surgical treatment can be recommended as a method of treating scleromalacia in clinical practice. Keywords: scleromalacia, rheumatoid arthritis, autograft, scleroplasty","PeriodicalId":18609,"journal":{"name":"Modern technologies in ophtalmology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139311757","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Dacryocystorhinostomywith transcutaneous access is not a reason for a cosmetological treatment 经皮穿刺的泪囊鼻腔造口术不是美容治疗的理由

Modern technologies in ophtalmology Pub Date : 2023-10-29 DOI: 10.25276/2312-4911-2022-6-141-144

N.E. Shanturova, O.A. Berdnikova, M.V. Shanturova

{"title":"Dacryocystorhinostomywith transcutaneous access is not a reason for a cosmetological treatment","authors":"N.E. Shanturova, O.A. Berdnikova, M.V. Shanturova","doi":"10.25276/2312-4911-2022-6-141-144","DOIUrl":"https://doi.org/10.25276/2312-4911-2022-6-141-144","url":null,"abstract":"External dacryocystorhinostomy is a highly effective surgery using for treatment the obstruction of the lacrimal ducts of various etiologies and is still relevant from the last century to the present. However, this method is quite labor-intensive for the surgeon, traumatic for the patient, and the result is not always cosmetically satisfactory, since one of the significant disadvantages of external dacryocystorhinostomy is the formation of a scar at the point of the skin incision. In modern conditions, the presence of a postoperative scar on the face brings some doubts among young patients, especially women, which inclines this group of patients towards choosing the endonasal approach, which in turn does not always lead to a positive result in restoring the patency of the lacrimal ducts. Various techniques for applying dacryocystorinoanastomosis and suturing the surgical wound present an extra complexity, and the formation of a postoperative skin scar that is cosmetically unsatisfactory for the patient is one of its main drawbacks in the modern terms of idea of an aesthetic result. The use of microsurgical technology, modern suture material is aimed to prevent the development of cicatricial deformation of the postoperative scar. The purpose of this work was to evaluate the cosmetic results of external dacryocystorhinostomy using the microsurgical technique of layer-by-layer tissue suturing. Keywords: external dacryocystorinostomy, dacryocystitis, suturing of a postoperative wound.","PeriodicalId":18609,"journal":{"name":"Modern technologies in ophtalmology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139311517","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

The incidence of meibomian gland dysfunction in children with certain types of chronic dermatoses 某些慢性皮肤病患儿睑板腺功能障碍的发生率

Modern technologies in ophtalmology Pub Date : 2023-10-29 DOI: 10.25276/2312-4911-2022-6-33-39

V.A. Bobryshev, V. Brzheskiy, D.V. Zaslavsky

{"title":"The incidence of meibomian gland dysfunction in children with certain types of chronic dermatoses","authors":"V.A. Bobryshev, V. Brzheskiy, D.V. Zaslavsky","doi":"10.25276/2312-4911-2022-6-33-39","DOIUrl":"https://doi.org/10.25276/2312-4911-2022-6-33-39","url":null,"abstract":"In order to investigate frequency of occurrence and features of the clinical course of dry eye syndrome (DES) in children of various ages with certain types of chronic dermatoses, 80 patients aged 4 to 17 years were examined. The criteria for their inclusion in the study were the presence of a verified diagnosis of atopic dermatitis (in the acute stage) (60 children) or ichthyosis (vulgar and congenital) (20 children). All were examined for the severity of subjective discomfort, the condition of the ocular surface, the production and stability of the pre-corneal tear film. The results obtained indicate the presence of clinical and functional signs of DES (mainly due to dysfunction of the meibomian glands) in 41 children (68.3 %) with atopic dermatitis and 15 (75.0 %) with ichthyosis. At the same time, in children with the studied types of chronic dermatoses, DES occurred mainly in mild and moderate forms. It is advisable to conduct an examination of patients with other forms of chronic dermatoses in order to identify and treat their meibomian gland dysfunction and the associated dry eye syndrome. Keywords: dysfunction of the meibomian glands, dry eye syndrome, chronic dermatoses, atopic dermatitis, ichthyosis.","PeriodicalId":18609,"journal":{"name":"Modern technologies in ophtalmology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139311587","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Modern approaches to the diagnosis and treatment of demodicosis 诊断和治疗脱皮症的现代方法

Modern technologies in ophtalmology Pub Date : 2023-10-29 DOI: 10.25276/2312-4911-2022-6-113-116

A.F. Smirnova, G. V. Kotlubey, V.S. Shevchenko, K. Golubov

引用次数: 0

The role of inflammation in pathogenesis of bullous kerathopathy 炎症在大疱性角化病发病机制中的作用

Modern technologies in ophtalmology Pub Date : 2023-10-29 DOI: 10.25276/2312-4911-2022-6-67-70

M. S. Denisko, T. A. Zhigalskaya, O. I. Krivosheina

{"title":"The role of inflammation in pathogenesis of bullous kerathopathy","authors":"M. S. Denisko, T. A. Zhigalskaya, O. I. Krivosheina","doi":"10.25276/2312-4911-2022-6-67-70","DOIUrl":"https://doi.org/10.25276/2312-4911-2022-6-67-70","url":null,"abstract":"Background. Bullous keratopathy is a chronic steadily progressive disease that leads to a significant decrease in vision and is accompanied by the appearance of a pronounced pain syndrome. Currently, the role of cytokines in the pathogenesis of the disease remains insufficiently studied. The aim of the study was to study the level of proinflammatory cytokines of the lacrimal fluid in bullous keratopathy. Results. There was a statistically significant increase of the level of proinflammatory cytokines in the lacrimal fluid of patients with bullous keratopathy: interleukin (IL) 1β by 3.6 times (p< 0.05) compared with the group of conditionally healthy volunteers (comparison group), IL-6 by 3.8 times (p< 0.05), the level of tumor necrosis factor (TNF) α– 2.0 times (p< 0.05). Conclusion. The bullous keratopathy is accompanied by a statistically significant increase in the concentration of proinflammatory cytokines in the lacrimal fluid of the diseased eye. The revealed feature of the local immune response in this pathology opens up prospects for new conceptual constructions of the pathogenesis of the bullous keratopathy with the subsequent development of effective methods of treating the disease. Keywords: bullous keratopathy, lacrimal fluid, proinflammatory cytokines, interleukins, inflammation","PeriodicalId":18609,"journal":{"name":"Modern technologies in ophtalmology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139311624","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0